Silodosin

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Benign Prostatic Hyperplasia

Conditions

Benign Prostatic Hyperplasia

Trial Timeline

May 1, 2011 โ†’ Aug 1, 2013

About Silodosin

Silodosin is a approved stage product being developed by Recordati for Benign Prostatic Hyperplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT01757769. Target conditions include Benign Prostatic Hyperplasia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01757769ApprovedCompleted

Competing Products

20 competing products in Benign Prostatic Hyperplasia

See all competitors